امور مالی

Johnson & Johnson stock after-hours at EUR 227.63: minus 1.39 percent versus prior close

At two years, 89% of patients taking J&J’s psoriasis pill had clear skin in affected genital areas.

Johnson & Johnson vs. Eli Lilly: Which Pharma Stock Can Make Your Portfolio Healthier in 2026?

Bristol-Myers Squibb vs. Johnson & Johnson: Comparing Quarterly Revenue Scale